<DOC>
	<DOC>NCT01085695</DOC>
	<brief_summary>The purpose of this study is to assess the pharmacokinetics of rabeprazole under fasting condition.</brief_summary>
	<brief_title>Study of E3810 for Healthy Japanese Male (Under Fasting Condition)</brief_title>
	<detailed_description>The purpose of this study is to assess bioequivalence after single administration of the following 4 types of formulation: normal 10 mg rabeprazole tablet rabeprazole, and Type 1, Type 2, and Type 3 granule formulation containing rabeprazole 10 mg.</detailed_description>
	<mesh_term>Rabeprazole</mesh_term>
	<criteria>Inclusion criteria: Subjects with homozygous or heterozygous extensive metabolizers of cytochrome P4502C19. Exclusion criteria: Subjects with allergy</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Rabeprazole</keyword>
	<keyword>Japan</keyword>
	<keyword>healthy Japanese male</keyword>
</DOC>